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chronic combined admlntstrati13n of vit13mln C and E can improve 13nd13th13- 
11131 function, we menaur13d f113w-mod113ted v,3nedl113tten (FMD, endotheltum- 
depend13nt vasedl113tlon) 13nd subtlngual glyc13ryl trinltmt13 Induc13d v~seddation 
(0,3 ms, GTN-D, ondothelium Independent vnsodilntton) In the brnchlnl ndery 
in 11 young chronic smok13rs aged 25 L 3 yeats by high rosolullon ultrttsou13d, 
FMD was m13asurod ,~s percent dt13meter chnngos from baseline to hyp13romlc 
conditions (1 mln ~lfter 5 sin occlusion of femerm artery), Each subjocle, had 
neither the other eomnnn/risk 113c(13m nor org,:lnlc dlseaso, FMD nnd GTN.D 
wore examined 0 limos in each ,ublect; at baseline, nf Iho end of 4 weeks 
oral administration of vitamin C (~ 9/dRy) rmd vitamin E (500 rag/day) 13nd Rt 4 
weeks alter cessation of vitamins, FMD wee slgniflc~ntly increased from u,~se. 
line In the treatment phase 13f vitamins and returned to baseline levels alter 
the oe.s~,~tlon, Vitnmtns had no affect on GTN.D, In ¢onclust13n, chronic corn. 
binod dleti't W t~Llpplomont of vitamin C ~nd E improves endothelial |unction 
nnd might h~vo provenlivo effect against the pmgret'~si13n of nthorasclorasis in 
smokes, H13w~ver, this bonefic~N 13fleet wt~ff rover~od ~fter cossnti13n, 
I~lll¢~etl~no Vd~mlns FIU 
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B~Ickgmund: Penpher131 End131heltal Dysfunclton tED) q~,~anlihod by the do. 
termination of Flow Mediated Dilation (FMO%) of the brachtat artery usmg 
hlgh-rasohdion ultrasound has boon ~podod to be an early marker of athoro- 
n~lemsts, Although a poo~itlvn corml,~tion with Coronmy Artery Disease (CAD) 
m discussed, lt~e potentiality ef FMD% to predict presence o¢ absence of CAD 
was to evaluate 
Meth('~'~: In this pro,'~pccflvo, doub113.bllnd 13tudy we moasuiod FMD% as 
a marker of E D, Wn sh~d~od 122 patients without peer tnvas=ve coronary ding- 
oestic13 who were .~ch13dulod lot co[an~lry anglog~aphy because of the clinical 
s~,~.~pi~....~ of CAD (sO~ 80 m/34 f, ,3go 66 t 8.6 yearn, BMI 27.0 ~ ks!m;') 
Boforo cometary anglegraphy, FMD% was measured using h~gh-resolut=on 
uttr~l.~ound (13 Mhz). LongttudinN scans of the brachial arto~ were done on 
B-sod13 • 10 cm above the elbow, at ro~t, dunng roact=vo hyperemia and after 
sublingual admm=strahon of nitrogtyconno. We defined ED as FMD 4,5%. 
The presence of CAD was dehned es angtograph~eally vlowable lesions of 
any dogn.',o. Stat*stlcal analysis was portonnod by t-test, numbers are g~ven 
as moans  t ~r3, 
Re,~ults: Patients wilh CAD had a significantly lower FMD"o than ~'~banls 
wdhout CAD (37 t 41% vs 70t ~ EI,5'~o, p-value . 0.001) Based en FMD 
,45% as a cut-oil point tot ED a s~,nsitivity of 0.71 (72/I01), a specdicily 
Of O,Rl i17t21), a positive predictive value el 095 (72/'/'6) and a negatwo 
predictive value oi 0.37 (11/461 was calculated. 
Conclusions: The non-invasivo determination of Penpheml Endothelial 
Dysfunction according to ~mp~ired Flow Mediated Vasodilatien of the braehial 
~dory w~s found to be n specific and sensitive method to predict the pros- 
once of CAD. This approach warronts further evaluation to determine its role 
as an additional screonmg test to standoff1 methods in patients with chmcal 
suspicion of CAD, 
• Determination of Time to Maximal Flow-mediated, 
Endothelial-dependent Vasodilator Response of the 
Brachlal Artery 
J.A. Arrowood, R. Feozor, M,R. Fisher, P.V. Ravindra, R,G. Makhoul, 
J V. Nixon. Me~ Coil of VA, Richmond. VA. USA 
Measurement of the change m brachial artery diameter (BAD) by high reso- 
lution ultrasound in response to hyperemia can be used to assess endothe- 
hal-dependent vasodilation. The point in time when the maximal vasedilatory 
response occurs has not been well characterized. 
Objective. To determine the time course of vasodilation by measuring BAD 
every 5 sec for 90se~s after distal hyperemia created by 4 .~ sin of for¢arm 
circulatory arrest. 86 SUblects we.re studied 22 to 61 yrs in agu including 49 
(57%) with ask facto~; for CAD 
Results: are shown in the histogram. Average maximum % dilation was 
93 ~t: 19%, Only 45% of patients had maximal BAD 45-60 sec post stimulus, 
whereas 91% reached maximal BAD between 25-70 sec. 
Conclusion: Contrary to accepted practice, BAD should be measured con- 
tinuously between 30 and 70 sec post stimulus to ensure dote 3tion of maximal 
vasodilatory response. 
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~42-5~_ EffQct of Melatonln on Vaacular Rea=t!vlty; 
- - - - -  A Croaa-over Double Blind Study In 
Po=t, menopauaal Women 
M.G Mod013~, R R13ss|, R Molln~n, N Muir, G. Oegttam, F. C~onml, 
A, Andes, A, C~slelh Dpt of Card,gigs k It, Unwe:s~t],, ot & ~ ,  ttah/ 
B~ickgrouf}d Melatan,n (MELt is a natural hoffnone with seVoral sl.ip.~osed 
v0so~¢ftve praporbes 
&.fethect~ In order to test the effects el MEL on the en(lothehal function 
we podenned a double bhnd cross-ovo~ study versus placebo ~n 18 Consec- 
uhve posheen13p~usal women (mean age: $3.24 t 4.24 years) Wome. with 
diabetes, hypertension, I~yporchotosteralem~ a:,d smokers were exek~k.--,d 
E13ch woman was randomized to oral placebo or MEL at the dose o! I mg and 
the day after crossed.over to the opposite treatment. Endothelial dependent 
v{~sodilaflon was studied. I hour ~lte~ the assumption o1 the drug, by mes- 
sy.inns the changes in brachiat artery dlamotor (BAd) and IIow attar reacttve 
hypotom~a Endothelial mdependcnt vasodllat~on was measured 3 mmutes 
alter 400 ~ g of spray subhngual mtmgfycenn 
ResultS; 
~..~.abtes Placebo MEL p 
BAll. ms. base 4 r t 13 4 408 ~ 13 5 O 8 
ioacttvo hyporomlll 4 a t 13 4 4 ~ t O 6 0 6 
atlo~ ntbostyc,elm 5 e t 13 4 4 I~O .. e 4 0 2, 
now mediated ilation 8 2 t 4 I 15 4 I 6 t e 135, 
Flow. mr(ms, t~)so 50 3 ~ 16 O t4 4 ~ 25, | O 05, 
reactive hypo~omta 765, : 26 13 75, 5, ~ 25 0 138 
¢'~ltov nltloglycerm 53 6 ~ 23 0 556 ~ 10 O O 6 
Conclusten: MEL seems to have a positive inlluenco on endolhehal depen- 
dent vasoddabon 
~_~]  Cholesterol Lowering With Pravastatin Improves 
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Medical College. Albany, NY, USA 
Background Improvement in epicard~al and resistance coronary endethehal 
function after cholesterol Iowenng has been demonstrated in pts with overt 
CAD but not in hyperchotesterolemic pls with nl cor. 
Methods: Twenty-four euglycemic pts with elevated LDL chol ( : 130 mg~dl) 
were placed on an AHA lipid Iowenng diet for 12 wks and then underwent 
baseline endothelial function k;sting utilizing graded intracoronary infusions 
of ACh. 
Results: Of 24, 14 {58%) were tound to have an abnormal resistance artery 
ddator response to ACh I. 150°o increase) and were candidates for random- 
tzation. One subject was not randnmlzed becaus~ of dietary noncompliance. 
The remaining 13 were ranaomly assigned in a double blind fashion to recewe 
either pravastatin (20--40 mg per day) or placebo for 6 months. Endothelial 
function testing was then repeated using the identical protocol. Of 8 pts re- 
ceiving pravastatin, peak increase in coronary blood flow (CBF) was 97 
10°,o at basehne and 140 :.~ 18% during restudy (p = 0.06). In six of these 
with nlcor, peak increase in CBF was 97 ~ 13% at baseline and 160 ± 16% 
after p, ~vastatin (p = 0.01). LDL chol was 151 ~. 8 at baseline and 112 ± 7 
mgldl at restudy (p = 0.005), Of 5 receiving placebo, 2 were excluded; one 
because of a technically poor study and one because of noncompliance, In 
the 3 placebo pts, peak CBF responses were 110 ± 16% and 120 ± 27% 
increase, respectively (p = NS). LDL chol was unchanged at 182 ± 14 and 
187 ~ 18 mg/dl, 
Conclusion: Treatment with pravastatin over 6 mGnt:~s led to significant 
lowering of LDL chol a,~d improved resistance artery ,,ndothelial function 
among pts with nl cor. Pt~cebo controls did not show this Oenefit. 
